Healthcare provider profile · identity verified

Susan L. Rapp, MD

Family Practice · WALNUT CREEK, CA · NPI 1154409225

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	553	188
Amlodipine Besylate	Amlodipine Besylate	421	145
Levothyroxine Sodium	Levothyroxine Sodium	410	121
Losartan Potassium	Losartan Potassium	370	120
Lisinopril	Lisinopril	297	107
Atenolol	Atenolol	271	88
Famotidine	Famotidine	187	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	185	39
Trazodone Hcl	Trazodone Hcl	175	64
Gabapentin	Gabapentin	173	63
Simvastatin	Simvastatin	162	52
Albuterol Sulfate Hfa	Albuterol Sulfate	145	68
Hydrochlorothiazide	Hydrochlorothiazide	143	48
Fluticasone Propionate	Fluticasone Propionate	141	53
Omeprazole	Omeprazole	120	45
Furosemide	Furosemide	110	42
Meloxicam	Meloxicam	105	31
Metformin Hcl	Metformin Hcl	102	34
Alendronate Sodium	Alendronate Sodium	101	35
Pantoprazole Sodium	Pantoprazole Sodium	98	29
Metoprolol Tartrate	Metoprolol Tartrate	97	35
Alvesco	Ciclesonide	92	33
Lovastatin	Lovastatin	82	26
Paxlovid	Nirmatrelvir/Ritonavir	81	81
Sertraline Hcl	Sertraline Hcl	80	35
Metformin Hcl Er	Metformin Hcl	79	28
Tizanidine Hcl	Tizanidine Hcl	74	23
Amoxicillin	Amoxicillin	73	42
Hydralazine Hcl	Hydralazine Hcl	73	26
Metoprolol Succinate	Metoprolol Succinate	72	28
Fluoxetine Hcl	Fluoxetine Hcl	70	25
Tamsulosin Hcl	Tamsulosin Hcl	67	28
Doxycycline Monohydrate	Doxycycline Monohydrate	63	49
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	23
Glipizide	Glipizide	57	21
Potassium Chloride	Potassium Chloride	57	22
Allopurinol	Allopurinol	55	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	52	40
Triamcinolone Acetonide	Triamcinolone Acetonide	51	27
Cephalexin	Cephalexin	50	38
Pravastatin Sodium	Pravastatin Sodium	50	14
Montelukast Sodium	Montelukast Sodium	48	18
Carvedilol	Carvedilol	44	12
Spiriva Respimat	Tiotropium Bromide	44	13
Duloxetine Hcl	Duloxetine Hcl	41	12
Fluocinonide	Fluocinonide	41	27
Ozempic	Semaglutide	41	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	41	14
Jardiance	Empagliflozin	40	13
Bupropion Xl	Bupropion Hcl	39	12
Citalopram Hbr	Citalopram Hydrobromide	35	11
Prednisone	Prednisone	35	24
Clobetasol Propionate	Clobetasol Propionate	33	21
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	32	12
Terazosin Hcl	Terazosin Hcl	31	suppressed
Acyclovir	Acyclovir	30	12
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	30	30
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	11
Ondansetron Odt	Ondansetron	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	20
Naproxen	Naproxen	27	12
Azelastine Hcl	Azelastine Hcl	26	11
Ibuprofen	Ibuprofen	26	13
Chlorthalidone	Chlorthalidone	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	11
Propranolol Hcl	Propranolol Hcl	25	12
Breyna	Budesonide/Formoterol Fumarate	24	suppressed
Finasteride	Finasteride	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	14
Pradaxa	Dabigatran Etexilate Mesylate	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Humulin N	Insulin Nph Human Isophane	23	suppressed
Lorazepam	Lorazepam	21	15
Trospium Chloride	Trospium Chloride	21	suppressed
Metronidazole	Metronidazole	20	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Cefadroxil	Cefadroxil	19	19
Humulin N Kwikpen	Insulin Nph Human Isophane	19	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Colchicine	Colchicine	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Digoxin	Digoxin	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	14	12
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Desonide	Desonide	12	11
Estradiol	Estradiol	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Torsemide	Torsemide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error